Opportunity

Simpler Grants.gov #HT942526ERPLRA

Army Solicitation for Epilepsy Research Leveraging Existing Resources

Buyer

Dept. of the Army -- USAMRAA

Posted

May 21, 2026

Respond By

August 17, 2026

Identifier

HT942526ERPLRA

NAICS

541715

The U.S. Army Medical Research Acquisition Activity (USAMRAA) is inviting applications for the FY26 Epilepsy Research Program (ERP) Leveraging Research Award. - Government Buyer: - Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), managed by Congressionally Directed Medical Research Programs (CDMRP) - Program Details: - Supports basic, translational, and/or clinical research focused on post-traumatic epilepsy (PTE) and its comorbidities - Research must repurpose or expand existing cohorts, resources, research tools, or interventions not previously focused on PTE - Approximately two awards anticipated, each up to $800,000, with a total program funding of $1,600,000 - Maximum period of performance is three years per award - Eligibility and Requirements: - Open to domestic and foreign organizations, for-profit and nonprofit entities, and public or private institutions - Each investigator may only be named as Principal Investigator on one application for this award cycle - Notable Aspects: - No specific OEMs, vendors, or product/equipment procurements are named, as this is a research grant opportunity - Focus is on leveraging existing research assets to accelerate PTE understanding

Description

The FY26 Epilepsy Research Program (ERP) Leveraging Research Award aims to support basic, translational, and clinical research that repurposes or expands existing research resources to accelerate understanding of post-traumatic epilepsy (PTE) and associated comorbidities. The research must adapt an existing cohort, resource, research tool, or intervention not previously focused on PTE. The program expects to fund approximately two awards with a total funding amount of $1,600,000 and a maximum cost cap of $800,000 per award. The maximum period of performance is three years, with awards funded by FY26 funds expiring on September 30, 2032.

View original listing